Compare Jubilant Pharmova with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA BIOCON JUBILANT PHARMOVA /
BIOCON
 
P/E (TTM) x 13.5 50.2 26.9% View Chart
P/BV x 1.9 6.2 30.3% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 JUBILANT PHARMOVA    BIOCON
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
BIOCON
Mar-21
JUBILANT PHARMOVA /
BIOCON
5-Yr Chart
Click to enlarge
High Rs727488 149.1%   
Low Rs230275 83.8%   
Sales per share (Unadj.) Rs574.759.2 970.6%  
Earnings per share (Unadj.) Rs56.47.7 731.3%  
Cash flow per share (Unadj.) Rs85.413.7 624.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs351.862.3 565.0%  
Shares outstanding (eoy) m159.281,200.00 13.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.86.4 12.9%   
Avg P/E ratio x8.549.4 17.2%  
P/CF ratio (eoy) x5.627.9 20.1%  
Price / Book Value ratio x1.46.1 22.2%  
Dividend payout %8.90-   
Avg Mkt Cap Rs m76,220457,350 16.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,27717,410 122.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m91,54471,058 128.8%  
Other income Rs m4746,052 7.8%   
Total revenues Rs m92,01877,110 119.3%   
Gross profit Rs m19,12413,145 145.5%  
Depreciation Rs m4,6197,151 64.6%   
Interest Rs m2,874577 498.1%   
Profit before tax Rs m12,10511,469 105.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,1232,215 141.0%   
Profit after tax Rs m8,9829,254 97.1%  
Gross profit margin %20.918.5 112.9%  
Effective tax rate %25.819.3 133.6%   
Net profit margin %9.813.0 75.3%  
BALANCE SHEET DATA
Current assets Rs m50,38376,004 66.3%   
Current liabilities Rs m26,19042,101 62.2%   
Net working cap to sales %26.447.7 55.4%  
Current ratio x1.91.8 106.6%  
Inventory Days Days7137 4.8%  
Debtors Days Days5263 82.4%  
Net fixed assets Rs m72,721106,142 68.5%   
Share capital Rs m1596,000 2.7%   
"Free" reserves Rs m55,88068,728 81.3%   
Net worth Rs m56,03974,728 75.0%   
Long term debt Rs m37,39729,616 126.3%   
Total assets Rs m123,104182,146 67.6%  
Interest coverage x5.220.9 25.0%   
Debt to equity ratio x0.70.4 168.4%  
Sales to assets ratio x0.70.4 190.6%   
Return on assets %9.65.4 178.4%  
Return on equity %16.012.4 129.4%  
Return on capital %16.011.5 138.9%  
Exports to sales %00-   
Imports to sales %14.87.2 206.3%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m13,5155,084 265.8%   
Fx inflow Rs m15,51511,791 131.6%   
Fx outflow Rs m13,5155,084 265.8%   
Net fx Rs m2,0006,707 29.8%   
CASH FLOW
From Operations Rs m15,42911,597 133.0%  
From Investments Rs m-3,270-36,247 9.0%  
From Financial Activity Rs m-10,50425,640 -41.0%  
Net Cashflow Rs m2,254723 311.8%  

Share Holding

Indian Promoters % 46.5 39.7 117.1%  
Foreign collaborators % 4.2 20.9 19.9%  
Indian inst/Mut Fund % 26.6 23.4 113.4%  
FIIs % 24.8 15.9 156.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 39.4 125.3%  
Shareholders   87,493 338,827 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   RAYMED LABS  PARNAX LAB  JUBILANT INGREVIA  SUN PHARMA  ORCHID PHARMA  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Aug 5, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - MANGALAM DRUGS COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS